3-carbonylamino-5-cyclopentyl-1 Fi-pyrazole compounds having inhibitory activity on CDK2
This invention relates to compounds of Formula (I), and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein R
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
17.11.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!